FOXO3 and neuroblastoma: By screening the Prestwick Chemical Library®, containing 1120 FDA-approved drugs, we recently identified and characterized carbenoxolone (CBX) as the first FOXO3 inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage NB [24].